Inflammatory Progressive Multifocal Leukoencephalopathy Without Immune Reconstitution in HIV: An Underrecognized Clinical Entity

Progressive multifocal leukoencephalopathy (PML) is a rare, acquired immune deficiency syndrome (AIDS)defining demyelinating disease caused by reactivation of the John Cunningham (JC) virus.It typically occurs in patients with advanced human immunodeficiency virus (HIV) infection and CD4 counts below 100 cells/mm³.This report describes an unusual case of microbiologically confirmed non-immune reconstitution inflammatory syndrome (non-IRIS) inflammatory PML in an antiretroviral therapy (ART)-naïve HIV patient with preserved immunity and an excellent long-term outcome.A male patient in his 40s presented with leftsided weakness, focal seizures, and a one-month history of headache.Brain magnetic resonance imaging (MRI) demonstrated multifocal asymmetric white matter lesions in the bilateral frontal and right temporoparietal regions, subcortical U-fibre involvement in the bilateral frontal lobes, subtle contrast enhancement, and hyperintense cortical signal (HCS), indicating inflammatory cortical involvement.Cerebrospinal fluid (CSF) analysis revealed a mildly elevated protein level, and JC virus polymerase chain reaction (PCR) was positive.HIV serology was positive, with a CD4 count of 212 cells/mm³.The patient was initiated on ART with tenofovir, emtricitabine, and efavirenz, as well as antiepileptic medications.Over more than seven years of follow-up, the patient demonstrated significant neurological recovery and radiological improvement, with only occasional breakthrough seizures and residual frontotemporal atrophy on MRI.Although inflammatory MRI features such as enhancement and HCS are often associated with PML-IRIS, this patient had not received ART prior to presentation.This case suggests the existence of a probable subset of non-IRIS inflammatory PML in ART-naïve HIV patients with relatively preserved CD4 counts.Early recognition of this atypical presentation is essential to avoid diagnostic delays and to facilitate timely ART initiation, which may improve long-term outcomes.

Authors

Publication Details

Journal
Cureus
Published
2026-11-14
DOI
https://doi.org/10.7759/cureus.119653
Primary Topic
Polyomavirus and related diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Inflammatory Progressive Multifocal Leukoencephalopathy Without Immune Reconstitution in HIV: An Underrecognized Clinical Entity

Aumir Moin, Vijay Halagappanavar Vamadevappa, Shraddha Kedlaya K., Dipin Dileep
1 links
Cureus
Polyomavirus and related diseases
article

Inflammatory Progressive Multifocal Leukoencephalopathy Without Immune Reconstitution in HIV: An Underrecognized Clinical Entity

Aumir Moin, Vijay Halagappanavar Vamadevappa, Shraddha Kedlaya K., Dipin Dileep
article en

Abstract

Progressive multifocal leukoencephalopathy (PML) is a rare, acquired immune deficiency syndrome (AIDS)defining demyelinating disease caused by reactivation of the John Cunningham (JC) virus.It typically occurs in patients with advanced human immunodeficiency virus (HIV) infection and CD4 counts below 100 cells/mm³.This report describes an unusual case of microbiologically confirmed non-immune reconstitution inflammatory syndrome (non-IRIS) inflammatory PML in an antiretroviral therapy (ART)-naïve HIV patient with preserved immunity and an excellent long-term outcome.A male patient in his 40s presented with leftsided weakness, focal seizures, and a one-month history of headache.Brain magnetic resonance imaging (MRI) demonstrated multifocal asymmetric white matter lesions in the bilateral frontal and right temporoparietal regions, subcortical U-fibre involvement in the bilateral frontal lobes, subtle contrast enhancement, and hyperintense cortical signal (HCS), indicating inflammatory cortical involvement.Cerebrospinal fluid (CSF) analysis revealed a mildly elevated protein level, and JC virus polymerase chain reaction (PCR) was positive.HIV serology was positive, with a CD4 count of 212 cells/mm³.The patient was initiated on ART with tenofovir, emtricitabine, and efavirenz, as well as antiepileptic medications.Over more than seven years of follow-up, the patient demonstrated significant neurological recovery and radiological improvement, with only occasional breakthrough seizures and residual frontotemporal atrophy on MRI.Although inflammatory MRI features such as enhancement and HCS are often associated with PML-IRIS, this patient had not received ART prior to presentation.This case suggests the existence of a probable subset of non-IRIS inflammatory PML in ART-naïve HIV patients with relatively preserved CD4 counts.Early recognition of this atypical presentation is essential to avoid diagnostic delays and to facilitate timely ART initiation, which may improve long-term outcomes.

Cureus
Good health and well-being
Polyomavirus and related diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon